New data shows Pfizer COVID-19 booster raises antibody levels in children 5-11
New data shows a booster dose of the Pfizer-BioNTech COVID-19 vaccine raised antibody levels in children ages 5 to 11.
Share:
More Stories
Hometown Heroes in the Hudson Valley
2ds ago1:28
Medical experts recommend to still take precautions following CDC's revised COVID isolation guidelines
147ds ago1:52
Judge: 3 men convicted in COVID-19 relief aid fraud
168ds ago1:47
Wondrous Things store in Briarcliff Manor to close after 34 years; everything 25% off
295ds ago0:28
Rockland small businesses get COVID-19 reimbursement grant
295ds ago
Nobel in medicine goes to 2 scientists whose work enabled creation of mRNA vaccines against COVID-19
298ds agoHometown Heroes in the Hudson Valley
2ds ago1:28
Medical experts recommend to still take precautions following CDC's revised COVID isolation guidelines
147ds ago1:52
Judge: 3 men convicted in COVID-19 relief aid fraud
168ds ago1:47
Wondrous Things store in Briarcliff Manor to close after 34 years; everything 25% off
295ds ago0:28
Rockland small businesses get COVID-19 reimbursement grant
295ds agoNobel in medicine goes to 2 scientists whose work enabled creation of mRNA vaccines against COVID-19
298ds ago
New data shows a booster dose of the Pfizer-BioNTech COVID-19 vaccine raised antibody levels in children ages 5 to 11.
The additional shot, given six months after the two-dose primary series, led to six times more antibodies against the original strain of the coronavirus.
Pfizer announced the trial results in a news release Thursday morning.
The data have not yet been made available to outside scientists for review.
